Structural Biology and Molecular Modeling Market to Witness Notable Growth by 2026

Comments · 604 Views

The global structural biology and molecular modeling market was valued at USD 4.00 billion in 2018 and is expected to reach USD 14.97 billion by the year 2026, at a CAGR of 17.9% .

According to the current analysis of Reports and Data, the global Structural Biology and Molecular Modeling Market was valued at USD 4.00 billion in 2018 and is expected to reach USD 14.97 billion by the year 2026, at a CAGR of 17.9%. The global structural biology and molecular modeling market is an essential part of the worldwide healthcare sector and has already made vital contributions in obtaining remedies to several diseases. The structural biology and molecular modeling field are concerned with an arrangement of various molecules in biological compounds and how the peculiarity of the arrangement affects the nature of the compound. The field also shows different alterations in the structure of the compounds affecting their environment and showing the position of each part of the structure, which is linked to the overall nature of the compound.

Improving the quality of medicine and healthcare, in general, has been a key focus of governments across the world in recent years due to the rising volume of patient demographics and the growing geriatric population. This has driven consistent investment in medical research in recent years, making steady development of the structural biology and molecular modeling techniques market likely in the future. Rising drug resistance coupled with high drug attrition rate is engendering the requirement for extensive RD activities, which is presumed to boost the adoption of structural biology molecular modeling techniques in the drug discovery and development process. The high cost of equipment may hamper the market growth.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.reportsanddata.com/download-free-sample/2233

Further key findings from the report suggest

  • Researchers of the University of Natural Resources and Life Sciences in Austria proceed out molecular dynamics simulations to study the activity of humanized antibodies (Ab2/3H6), which is believed to neutralize HIV-1.
  • Large drug attrition rate associated with late-phase clinical trials in drug development is a significant contributor of the elevated costs, which is further presumed to propel the demand for modeling techniques to reduce the probability of drug failure.
  • Potency determination of a new drug molecule in the silicon screening of 3-D chemical structures expedite the lead discovery and optimization process, thereby allowing the greater focus to be laid on targets with high therapeutic potential.
  • North America captured a dominant share in the overall structural biology molecular modeling techniques market with 35%. Heightening their RD capabilities to ensure high medical standards is expected to propel the demand in this region.
  • Threading is valued at 883.9 million in 2018 and expected to reach 3.23 billion in 2026 by increasing technological advancements in threading segment.
  • Molecular dynamics is the fastest-growing segment with CAGr of 17.7% and expected to reach 2.61 billion in 2026.
  • Stringent regulation by government and availability of alternatives is one of the restraints to this market growth.

Competitive Outlook of the Global Structural Biology and Molecular Modeling Market

The globla Structural Biology and Molecular Modeling market study focuses on the revenue growth trajectories of the leading companies in this market. This section of the report throws light on the highly competitive landscape of the Structural Biology and Molecular Modeling market, pointing out the major players. The report further discusses the strategic initiatives undertaken by each of these market players, including mergers acquisitions, collaborations, joint ventures, new product launches, new business deals, and technological innovations.

Top Companies Profiled in the Report:

AlDassault Systemes, Agile Molecule, Accellera Ltd., Bioinformatic LLC, Affymetrix, Agilent Technologies, Inc., Illumina, Bruker Daltonics Inc., Biomax Informatics AG, Chemical Computing Group, and CLC bio.

Inquiry Before Buying @ https://www.reportsanddata.com/inquiry-before-buying/2233

The report is inclusive of product type outlook, application spectrum, end-use outlook, technology landscape, regional market analysis, and competitive overview.

Structural Biology and Molecular Modeling Market Segmentation:

Tools (Revenue, USD Million; 2016–2026)

  • SaaS standalone modeling
    • Homology modeling
    • Threading
    • Molecular dynamics
    • Ab Initio
    • Hybrid
    • Others
  • Visualization analysis
  • Databases
  • Others

Application (Revenue, USD Million; 2016–2026)

  • Drug development
  • Drug discovery
  • Others

Geographic Segment Covered in the Report:

The Structural Biology and Molecular Modeling report provides information about the market area, which is further subdivided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and growth rate of each region, country, and sub-region during the estimated period.

  • North America (USA and Canada)

  • Europe (UK, Germany, France and the rest of Europe)

  • Asia Pacific (China, Japan, India, and the rest of the Asia Pacific region)

  • Latin America (Brazil, Mexico, and the rest of Latin America)

  • Middle East and Africa (GCC and rest of the Middle East and Africa)

Request customization of the report @ https://www.reportsanddata.com/request-customization-form/2233

Thank you for reading our report. Customization of this report is available as per the client’s requirements. Please connect with us to know more about the report and our team will ensure you get the report tailored according to your needs.

Get Explore Latest Research Report by Reports and Data:

Alpha-Adrenoreceptor Antagonists Market @ https://www.biospace.com/article/alpha-adrenoreceptor-antagonists-market-size-share-leaders-current-status-by-major-key-vendors-and-trends-by-forecast-to-2027/

Preclinical Tomography System Market @ https://www.biospace.com/article/preclinical-tomography-system-market-size-share-industry-key-features-growth-drivers-key-expansion-strategies-upcoming-trends-and-regional-forecast-by-2027/

Pediatric Hearing Aids Market @ #VALUE!

Physical Vapor Deposition (PVD) Medical Devices Market @ https://www.biospace.com/article/physical-vapor-deposition-pvd-medical-devices-market-size-competitors-strategy-regional-analysis-and-industry-growth-by-forecast-to-2028/

Sodium Polystyrene Sulfonate Powder Market @ https://www.biospace.com/article/sodium-polystyrene-sulfonate-powder-market-analysis-development-opportunities-future-growth-and-business-prospects-by-forecast-to-2027/

Diabetes Market @ https://www.biospace.com/article/diabetes-market-size-developments-status-trends-and-key-players-analysis-forecast-2027/

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

Comments